Alembic Pharmaceuticals
Tracked across 3 events · 26 articles · First seen Jun 08, 2026 · Last active Sep 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Alembic will distribute the generic Olaparib in the US, expanding its oncology portfolio and addressing a $1.4B market. The tentative approval is a positive regulatory milestone, but commercial launch depends on litigation outcome.
Jul 19, 2026 · 6 articles
Tech
Impact: Alembic Pharmaceuticals, through its Group Leader Ashish Kanhed, provided positive feedback on the performance of the new BioResolve Peptide RP Columns.
Jun 08, 2026 · 10 articles
Business
Prasol Chemicals Limited Ltd., an Indian specialty chemicals manufacturer, launched its initial public offering (IPO) on September 8, 2026. The book-built issue of Rs 500 crore comprises a fresh issue of 11.83 lakh shares (Rs…
Impact: Key customer of Prasol Chemicals Limited, mentioned as part of its customer base. The IPO does not directly affect them.
Sep 03, 2026 · 10 articles
ERGEN INTELLIGENCE
Track Alembic Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard